Esmail, E., El-rashidy, M., Mashhour, H., Abo-Safia, H. (2023). Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer. test, 7(1), 55-67. doi: 10.21608/jcbr.2023.181487.1287
Eman Basiouny Esmail; Mohammed Ali El-rashidy; Heba Abd El-hai Mashhour; Hend Salah Abo-Safia. "Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer". test, 7, 1, 2023, 55-67. doi: 10.21608/jcbr.2023.181487.1287
Esmail, E., El-rashidy, M., Mashhour, H., Abo-Safia, H. (2023). 'Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer', test, 7(1), pp. 55-67. doi: 10.21608/jcbr.2023.181487.1287
Esmail, E., El-rashidy, M., Mashhour, H., Abo-Safia, H. Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer. test, 2023; 7(1): 55-67. doi: 10.21608/jcbr.2023.181487.1287